NANOBIOTIX S.A. SP.ADR Financial Flexibility Index

Latest as of December 2025: -0.22x

NANOBIOTIX S.A. SP.ADR financial flexibility index. NANOBIOTIX S.A. SP.ADR (5NRA) has a Financial Flexibility Index of -0.22x as of December 2025. Free cash flow of €-32.88 Million (operating CF €-33.42 Million minus capex €546.00K) represents 0% of total liabilities (€152.24 Million).

Financial Flexibility Index

-0.22x
Free Cash Flow / Total Liabilities

Free Cash Flow

€-32.88 Million
Operating CF − Capex

Total Liabilities

€152.24 Million
EUR

Capital Expenditures

€546.00K
EUR

Financial Flexibility Index of NANOBIOTIX S.A. SP.ADR (2021–2025)

Financial flexibility index of NANOBIOTIX S.A. SP.ADR from 2021 to 2025. Historical Financial Flexibility Index trend for NANOBIOTIX S.A. SP.ADR across 5 annual periods. Explore 5NRA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

NANOBIOTIX S.A. SP.ADR Financial Flexibility Index by Year (2021–2025)

NANOBIOTIX S.A. SP.ADR financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for NANOBIOTIX S.A. SP.ADR. For the full cash flow conversion analysis, see 5NRA cash flow conversion.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2025 -0.22x €-32.88 Million €-33.42 Million €152.24 Million ▼ -53.7%
2024 -0.14x €-18.70 Million €-19.55 Million €133.12 Million ▼ -10.8%
2023 -0.13x €-12.14 Million €-12.48 Million €95.74 Million ▲ +70.3%
2022 -0.43x €-37.01 Million €-37.10 Million €86.81 Million ▼ -7.8%
2021 -0.40x €-29.64 Million €-29.87 Million €74.98 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities